
Episode 28: Hatteras Venture Partners' Clay Thorp
BioVenture VoiCes with Chris Garabedian
00:00
Histosonics: long-term portfolio success
Clay narrates Histosonics' 2009 Series A, pivots, regulatory approvals, and its $2.25B sale and concurrent growth financing.
Play episode from 49:47
Transcript


